Abstracts

Submission is OPEN through Aug. 15.

Join ASGCT for an unparalleled opportunity to immerse yourself in the latest research related to cell and gene therapy for cancer October 15-16, 2025, in vibrant downtown Philadelphia. 

Our 1.5-day conference is tailor-made for researchers and clinicians who are passionate about advancing cancer treatment through cell and gene therapy. Share your groundbreaking work, engage in thought-provoking discussions, and explore potential collaborations with peers from around the globe. 

Submit an abstract       Register to attend

Important Dates

Author Registration Discounts

ASGCT members can save up to $200 on registration, and Associate Members (students and postdoctoral fellows) who are first and presenting authors can also get a discounted* registration rate of $175.

*Discounted rates do not apply if your abstract is withdrawn or rejected.

Submit an abstract       Register to attend

Embargo Policy

The full text of accepted abstracts will be made available to media registrants on Sept.16, two weeks before the content goes live to the public. Abstracts will be released on Sept. 30 at 4:30 p.m. ET.

Researchers and presenters are free to discuss the content of their abstracts throughout this embargo period, but any abstract-related content may not be published until the abstracts are publicly released online.   

Updated data, new graphics, and follow-up information to be presented during oral presentation sessions is embargoed until 6 a.m. on the presentation day.   

Updated data, new graphics, and follow-up information to be presented via ePoster is embargoed until 6 a.m. ET on the first day of the meeting, Oct. 15. 

ASGCT will publish the titles and authors in the abstract collection upon the acceptance of notification on Sept. 8. After an abstract author has accepted their presentation role, the author and their organization are encouraged to publicize the title, author name, and presentation time across any channels they'd like, tagging ASGCT where applicable. 

General Requirements

• All abstracts are capped at 3,500 characters NOT including spaces.  

• All abstracts must be submitted in clear and concise English. Spelling may be in U.S. English or UK English. 

• Remove all track changes before submitting your abstract; these changes can be picked up with copy and paste functions, making the abstract incoherent. 

• The title should be entered exactly as it is to appear online—titles should be submitted in sentence case AMA formatting. You may use this text converter to help create the perfect title.  

  • Here is an example of a sentence case abstract title:  
    A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice. 

• The names, prefixes, email addresses, and institutional affiliations of all co-authors must be provided at time of submission. 

  • Any names excluded in submission will not be listed in the author block of the publication.  

  • Co-authors will also be asked to fill out their financial disclosures. 

• It is the responsibility of the submitter to proofread the abstract and author list carefully. Abstracts will be published as submitted. 

• Tables and figures may be uploaded via a photo file type, .jpeg, .jpg, or .png. 

  • Each abstract is limited to two uploads. 

  • Figures should be labeled with a number and/or caption as a footer. 

• The abstract should be structured. 

  •  i.e. Divided into sections: introduction, methods, results, conclusions 

• Do not use bold type or underline formatting—italic type is acceptable. 

• Changes to abstract content and author block may be made by the submitter prior to the close of the submission deadline. 

• Edit requests to submissions following the submission deadline are not guaranteed. No changes will be made after the withdrawal deadline. 

• The presenting author of abstracts selected for Oral or Poster presentation must attend the event in person. If the original designated presenting author cannot attend, a co-author may be designated as an alternative presenter. Please submit presenting author changes to abstracts@asgct.org.  

• ASGCT does not accept abstracts that have been published before or that are overly commercial or proprietary in nature. 

Tips for Submitting the Best Abstract 

• Clarity is vital. 

• Highlight new and novel aspects and be clear about what advancements you have made. 

• Clarify the problem, then describe how your work solves the problem or how it fills a gap or an unknown in the field. 

• Clearly describe the model system(s) used. 

  • Technical innovations should be contextualized with relevant model systems, so that reviewers can understand the value of these important studies. 

• Highlight the results found. 

• Avoid too many background details—get to the point. 

• Keep in mind the audience that is reviewing your abstract (scientific researchers, clinicians, industry scientists, and academics who specialize in their category) make sure there is enough data in the abstract to be reviewed by this audience. 

• Do not simply describe your conclusions: place your findings within the context of the field. How does your work impact past, present, and/or future research? 

• Edit and proofread your abstract—if needed, use English editing support. 

Use of AI: Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author or be cited as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans. 

Ready to Register?

Register to join us today!